Peter K. Leichner

2.9k total citations
69 papers, 2.3k citations indexed

About

Peter K. Leichner is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Peter K. Leichner has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Hepatology. Recurrent topics in Peter K. Leichner's work include Radiopharmaceutical Chemistry and Applications (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Medical Imaging Techniques and Applications (12 papers). Peter K. Leichner is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Medical Imaging Techniques and Applications (12 papers). Peter K. Leichner collaborates with scholars based in United States, Sweden and Canada. Peter K. Leichner's co-authors include Stanley E. Order, J Klein, Jerry L. Klein, David S. Ettinger, William G. Hawkins, S S Siegelman, Gary B. Stillwagon, H. M. Vriesendorp, Elliot K. Fishman and Kent F. Palmer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Peter K. Leichner

68 papers receiving 2.1k citations

Peers

Peter K. Leichner

RNMI

PRM

ONCOL

HEPAT

RADIA

Eric P. Visser Netherlands

Masayuki Matsuo Japan

R.J. Ott United Kingdom

James P.B. O’Connor United Kingdom

Christian Plathow Germany

G. Gademann Germany

Bruce N. Gray Australia

Thomas Carlier France

M. Mitze Germany

Tina M. Briere United States

Eric P. Visser Netherlands

Peter K. Leichner

2.2k ×1.7

RNMI

694 ×1.3

PRM

340 ×0.8

ONCOL

84 ×0.2

HEPAT

399 ×1.3

RADIA

Citations per year, relative to Peter K. Leichner Peter K. Leichner (= 1×) peers Eric P. Visser

Countries citing papers authored by Peter K. Leichner

Since Specialization

Citations

This map shows the geographic impact of Peter K. Leichner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Leichner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Leichner more than expected).

Fields of papers citing papers by Peter K. Leichner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Leichner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Leichner. The network helps show where Peter K. Leichner may publish in the future.

Co-authorship network of co-authors of Peter K. Leichner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Leichner. A scholar is included among the top collaborators of Peter K. Leichner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Leichner. Peter K. Leichner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adelstein, S. James, Roger W. Howell, John L. Humm, et al.. (2002). Absorbed-Dose Specification in Nuclear Medicine: Abstract. Journal of the ICRU. 2(1). 9–9. 7 indexed citations

Adelstein, S. James, Roger W. Howell, John L. Humm, et al.. (2002). 5 Techniques and Procedures. Journal of the ICRU. 2(1). 71–85. 2 indexed citations

Klein, J, et al.. (1995). Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment.. Journal of Clinical Oncology. 13(9). 2394–2400. 34 indexed citations

Dalrymple, Glenn V., Peter K. Leichner, Katherine Harrison, et al.. (1994). Induction of high grade astrocytoma (HGA) by protons: Molecular mechanisms and RBE considerations. Advances in Space Research. 14(10). 267–270. 5 indexed citations

Quadri, Syed M., Huibert M. Vriesendorp, Peter K. Leichner, & Jerry R. Williams. (1993). Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs.. PubMed. 34(6). 938–45. 23 indexed citations

Quadri, Syed M., et al.. (1993). Preclinical evaluation of intravenously administered 111in- and 90y-labeled b72.3 immunoconjugate (GYK-DTPA) in beagle dogs. Nuclear Medicine and Biology. 20(5). 559–570. 12 indexed citations

Leichner, Peter K. & Cheuk S. Kwok. (1993). Tumor dosimetry in radioimmunotherapy: Methods of calculation for beta particles. Medical Physics. 20(2). 529–534. 21 indexed citations

Rahmouni, Alain, Andrew Yang, Clare M. Tempany, et al.. (1992). Accuracy of In-Vivo Assessment of Prostatic Volume by MRI and Transrectal Ultrasonography. Journal of Computer Assisted Tomography. 16(6). 935–940. 100 indexed citations

Stillwagon, Gary B., Stanley E. Order, Clare E. Guse, et al.. (1991). Prognostic factors in unresectable hepatocellular cancer: Radiation therapy oncology group study 83-01. International Journal of Radiation Oncology*Biology*Physics. 20(1). 65–71. 32 indexed citations

10.

Vriesendorp, H. M., et al.. (1991). Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.. Journal of Clinical Oncology. 9(6). 918–928. 102 indexed citations

11.

Epstein, Barry E., Peter K. Leichner, Stanley E. Order, & David S. Ettinger. (1991). Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma. Cancer. 67(4). 896–900. 24 indexed citations

12.

Order, Stanley E., Thomas Pajak, Sucha O. Asbell, et al.. (1991). A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study. International Journal of Radiation Oncology*Biology*Physics. 20(5). 953–963. 38 indexed citations

13.

Stillwagon, Gary B., Stanley E. Order, Clare E. Guse, et al.. (1989). 194 Hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: A radiation therapy oncology group study. International Journal of Radiation Oncology*Biology*Physics. 17(6). 1223–1229. 78 indexed citations

14.

Vriesendorp, H. M., et al.. (1989). Polyclonal 90yttrium labeled antiferritin for refractory Hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics. 17(4). 815–821. 43 indexed citations

15.

Epstein, Barry E., David S. Ettinger, Peter K. Leichner, & Stanley E. Order. (1989). Multimodality cisplatin treatment in nonresectable afp positive hepatoma: Preliminary results. International Journal of Radiation Oncology*Biology*Physics. 17. 185–185. 3 indexed citations

16.

Hawkins, William G., et al.. (1988). The circular harmonic transform for SPECT reconstruction and boundary conditions on the Fourier transform of the sinogram. IEEE Transactions on Medical Imaging. 7(2). 135–138. 77 indexed citations

17.

Sitzmann, James V., Stanley E. Order, J Klein, et al.. (1987). Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer.. Journal of Clinical Oncology. 5(10). 1566–1573. 40 indexed citations

18.

Leichner, Peter K., et al.. (1987). Effective atomic numbers for low‐energy total photon interactions in human tissues. Medical Physics. 14(5). 759–766. 43 indexed citations

19.

Leichner, Peter K., Jerry L. Klein, Elliot K. Fishman, et al.. (1984). Comparative Tumor Dose from ¹³¹ I-Labeled Polyclonal Ariti-Ferritin, Ariti-AFP, and Anti-CEA in Primary Liver Cancers. PubMed. 1(4). 321–328. 15 indexed citations

20.

Rosenshein, Neil B., Peter K. Leichner, & Georgia B. Vogelsang. (1979). Radiocolloids in the Treatment of Ovarian Cancer. Obstetrical & Gynecological Survey. 34(9). 708–720. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact